24 August 2015: advertising an unlicensed medicine
Published 10 September 2015
© Crown copyright 2015
This publication is licensed under the terms of the Open Government Licence v3.0 except where otherwise stated. To view this licence, visit nationalarchives.gov.uk/doc/open-government-licence/version/3 or write to the Information Policy Team, The National Archives, Kew, London TW9 4DU, or email: psi@nationalarchives.gov.uk.
Where we have identified any third party copyright information you will need to obtain permission from the copyright holders concerned.
This publication is available at https://www.gov.uk/government/publications/advertising-investigations-august-2015/24-august-2015-advertising-an-unlicensed-medicine
MHRA received a complaint about a commercial feature in a Raconteur supplement on cancer treatments sponsored by Northwest Biotherapeutics that was published on 4 June 2015 in the Times. The complainant was concerned that the feature promoted DCVax-L, an unlicensed medicine.
MHRA upheld the complaint and considered that the commercial feature was an advert for a medicine that did not have a valid marketing authorisation in the UK. Advice on our interpretation of the law was provided to Northwest Biotherapeutics.